A Hayward
- Nephrology top 5%
- Chronic Kidney Disease and Diabetes 2
- Renal Diseases and Glomerulopathies 2
- Clinical Biochemistry top 10%
-
- Immune Response and Inflammation 1
-
- Diabetes and associated disorders 1
-
- Peroxisome Proliferator-Activated Receptors 5
-
- NF-κB Signaling Pathways 4
-
- Adipokines, Inflammation, and Metabolic Diseases 2
-
- Pregnancy and preeclampsia studies 1
A Hayward
9 papers receiving 352 citations
Peers
Comparison fields: 5 of 54
- Nephrology 181
- Clinical Biochemistry 43
- Endocrinology, Diabetes and Metabolism 70
- Immunology 66
- Genetics 84
Countries citing papers authored by A Hayward
This map shows the geographic impact of A Hayward's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A Hayward with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A Hayward more than expected).
Fields of papers citing papers by A Hayward
This network shows the impact of papers produced by A Hayward. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A Hayward. The network helps show where A Hayward may publish in the future.
Co-authorship network
The 25 scholars most cited alongside A Hayward, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 16 | |
| 2 | 2010 | 16 | |
| 3 | 2009 | 78 | |
| 4 | 2008 | 90 | |
| 5 | 2005 | 76 | |
| 6 | Rosiglitazone prevents stretch-induced monocyte recruitment by inhibiting the NFkB-MCP1 pathway in human mesangial cells. | 2003 | 2 |
| 7 | Rosiglitazone prevents stretch-induced monocyte recruitment by inhibiting the NFkB-MCP-1 pathway in human mesangial cells | 2003 | 1 |
| 8 | Mechanical stretch and cytokines upregulate vascular endothelial growth factor and its receptors in glomerular epithelial cells in vitro. | 2003 | 1 |
| 9 | Rosiglitazone prevents stretch-induced MCP-1 production in human mesangial cells | 2002 | 2 |
| 10 | 1999 | 81 | |
| 11 | Relationship between the pharmacological and biochemical properties of a monoamine oxidase inhibitor preferentially affecting 5-hydroxytryptamine oxidation. | 1970 | 1 |
About A Hayward
A Hayward is a scholar working on Nephrology, Cancer Research and Immunology and Allergy, having authored 11 papers that have together received 364 indexed citations. Recurring topics across this work include Peroxisome Proliferator-Activated Receptors (5 papers), NF-κB Signaling Pathways (4 papers), Adipokines, Inflammation, and Metabolic Diseases (2 papers), Chronic Kidney Disease and Diabetes (2 papers), Renal Diseases and Glomerulopathies (2 papers), Pregnancy and preeclampsia studies (1 paper), Diabetes and associated disorders (1 paper) and Immune Response and Inflammation (1 paper). The work is most often cited by research in Nephrology (181 citations), Clinical Biochemistry (43 citations) and Endocrinology, Diabetes and Metabolism (70 citations). A Hayward has collaborated with scholars based in United Kingdom, Australia and Canada. Frequent co-authors include Luigi Gnudi, Giancarlo Viberti, Alessandra Dei, Holley F. Allen, H. Peter Chase, Paul N. Jensen, Eric A. F. Simões, Kathryn White, Marc‐Olivier Baradez and Gabriella Gruden. Their work appears in journals such as Journal of the American Society of Nephrology, Diabetes, Diabetologia, American Journal of Nephrology and Diabetic Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.